Kite Pharma, Inc. Retained Earnings
Kite Pharma, Inc. had Retained Earnings of -$626.95 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2017-08-08
- 2017-06-30: Retained Earnings (Accumulated Deficit) -$626.95M.
- 2017-03-31: Retained Earnings (Accumulated Deficit) -$517.13M.
- 2016-12-31: Retained Earnings (Accumulated Deficit) -$426.73M.
- 2016-09-30: Retained Earnings (Accumulated Deficit) -$341.79M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2017-06-30 | -$626.95M 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$517.13M 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$426.73M 10-Q · filed 2017-08-08 |
| 2016-09-30 | -$341.79M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$267.85M 10-Q · filed 2016-08-08 |
| 2016-03-31 | -$203.57M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$159.66M 10-K · filed 2017-02-28 |
| 2015-09-30 | -$121.43M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$93.98M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$73.09M 10-Q · filed 2015-05-15 |
| 2014-12-31 | -$58.00M 10-K · filed 2016-02-29 |
| 2014-09-30 | -$44.99M 10-Q · filed 2014-11-14 |
| 2014-06-30 | -$35.93M 10-Q · filed 2014-08-14 |
| 2013-12-31 | -$15.44M 10-K · filed 2015-03-26 |